Finance and efficiency

Expensive drugs to be cut from cancer drugs fund

By 2014-11-11T10:39:00

Packets of drugs

NHS England is to start evaluating the cost effectiveness of medicines available through the cancer drugs fund in a bid to bring the budget under control

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Alternatively, click here to register for free to keep reading this article and to receive our daily news alerts

Subscribe

to HSJ

Sign into your account here